The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Concurrent trastuzumab deruxtecan and radiation therapy in HER2-positive and HER2-low metastatic breast cancer: Assessing the efficacy.
 
Jihane Bouziane
No Relationships to Disclose
 
Pierre Loap
No Relationships to Disclose
 
Sofiane Allali
No Relationships to Disclose
 
Laurence Escalup
No Relationships to Disclose
 
Jean-Yves Pierga
Honoraria - Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); Novartis (Inst)
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Eisai Europe (Inst); Exact Sciences; Gilead Sciences; Lilly; Menarini Group; MSD Oncology; MSD Oncology (Inst); Novartis; Pfizer; Roche/Genentech; Roche/Genentech (Inst); Seagen; Veracyte
Research Funding - Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Pfizer
 
Youlia Kirova
No Relationships to Disclose